Procedurally similar competitive enzyme-linked immunoassay (cELISA) methods were developed for the serodiagnosis of Babesia equi and Babesia caballi (piroplasmosis), Trypanosoma equiperdum (dourine), and Burkholderia mallei (glanders) infections in horses. Apparent test specificities for the B. equi, B. caballi, T. equiperdum, and B. mallei cELISAs were 99.2%, 99.5%, 98.9%, and 98.9%, respectively. Concordances and kappa values between the complement fixation (CF) and the cELISA procedures for the serodiagnosis of B. equi, B. caballi, T. equiperdum, and B. mallei infections in experimentally exposed horses were 76% and 0.55, 89% and 0.78, 97% and 0.95, and 70% and 0.44, respectively. The cELISA method may be a technically more reproducible, objective, and convenient approach for piroplasmosis, dourine, and glanders serodiagnosis in qualifying animals for international movement and disease eradication programs than the CF systems currently in use. Use of the cELISA method also obviated the problems associated with testing hemolyzed or anticomplementary sera.
Piroplasmosis, dourine, and glanders are internationally reportable, serious infectious diseases of Equidae. 1, 3 The etiologic agents of these diseases are unrelated. Piroplasmosis results from Babesia equi or Babesia caballi infection, whereas dourine and glanders result from Trypanosoma equiperdum and Burkholderia mallei infections respectively. 1, 3 Many nations require that Equidae presented for importation be serologically negative to B. equi, B. caballi, T. equiperdum, and B. mallei. 1, 3, 10 Traditionally, a panel of 4 separate complement fixation (CF) procedures has been the primary serodiagnostic tool prescribed by the Office International des Epizooties (OIE) for this purpose. 2, 3 The OIE has also recognized alternative serodiagnostic methods for each etiologic agent, including separate indirect fluorescent antibody tests (IFATs) for B. equi and B. caballi, enzyme-linked immunosorbent assay (ELISA) for B. mallei, and ELISA, IFAT, or agar gel immunodiffusion procedures for T. equiperdum serodiagnosis. 4, 6, 7, 12, 13, 17 In practice, the battery of 4 CF procedures has been the most convenient, rapid, single test system for accomplishing the required piroplasmosis, dourine, and glanders serodiagnostic testing. Unfortunately, the CF tests require careful continuous titration of numerous labile reagents and, for piroplasmosis, the laborious expensive preparation of antigen from infected splenectomized horses. 2, 3 These CF procedures do not function with sera having anticomplementary activity, test interpretation is often subjective, test sensitivity is low relative to more modern immunoassay methods, and CF test sensitivity declines as the serologic responses of exposed animals shift from initial IgMbased reactions to those of other immunoglobulin classes and subclasses. 6, 7, 9, 11, 12 This report describes a single, rapid, simple protocol for the competitive ELISA (cELISA) of equine serum designed to replace the current CF procedures for the serodiagnosis of piroplasmosis, dourine, and glanders.
Materials and methods

Antigens
Piroplasmosis. Recombinant B. equi and B. caballi immunodominant merozoite proteins were used for the piroplasmosis cELISAs. 8, 11 The B. equi antigen was produced by expressing plasmid pEMA-1 in Escherichia coli as described to yield a 43-kD recombinant fusion protein. 11, 14 This fusion protein included within it the serodominant 34-kD EMA-1 surface epitope of B. equi defined by monoclonal antibody 36/133.97. 8 The B. caballi antigen was produced similarly in E. coli with plasmid Z2, which encoded a 10-kD subunit of the serodominant B. caballi 60-kD RAP-1 protein homolog. 8, 14 Dourine. Intact T. equiperdum organisms were isolated from the blood of infected rats as previously described. [2] [3] [4] These organisms were then sonicated to clarity in a 0.01 M phosphate-buffered saline (PBS) solution, pH 7.4, containing a commercial mixture of broad-spectrum protease inhibitors. a The sonicate was used without further processing as the T. equiperdum cELISA antigen.
Glanders. Mallein, a heat-killed, primarily lipopolysaccharide (LPS) extract of B. mallei, was used as the glanders cELISA antigen. 7, 13 Both piroplasmosis antigens, the dourine antigen, and the glanders antigen were stored at Ϫ70 C until used.
Indicator antibodies
Piroplasmosis. Ascites, containing murine monoclonal antibodies 36/133.97 or 79/17.8.5, were used as the competing indicator antibody reagents in the B. equi and B. caballi cELISAs, respectively. 8, 11 Dourine. A gnotobiotic calf was inoculated intramuscularly on 4 occasions at 3-wk intervals with 2 ml of sonicated T. equiperdum organisms suspended in R-730 adjuvant b as recommended by the manufacturer. Serum from the calf was used as the dourine cELISA indicator reagent.
Glanders. Irradiation-killed B. mallei cells c were used as the immunogen for the production of anti-B. mallei monoclonal antibodies in BALB/c mice. Antibodies from 1 resulting hybridoma, anti-BMAL, reacted specifically with B. mallei LPS. Ascites produced with the anti-BMAL hybridoma were used as the indicator reagent for the glanders cELISA.
Serum samples
Three categories of equine sera were used to evaluate and to set the positive-negative cutoff endpoints for each of the 4 cELISAs. A bank of 1,000 sera d from United States-origin horses was used as a gold standard negative population to represent samples from animals not exposed to piroplasmosis, dourine, and glanders because these diseases do not presently occur in the USA. A second group of 4 pairs of equine sera d (Table 1 ) was used as a cELISA positive control serum panel. These sera had all been used previously as positive control sera for the piroplasmosis, dourine, and glanders CF procedures conducted as prescribed by the OIE. 2 One pair of sera was monospecifically positive for each of the 4 etiologic agents, 1 serum in each pair being highly CF reactive and the second being relatively weaker. The 4 weak-positive control sera were further diluted in normal horse sera to their CF titration endpoints. These diluted weak-positive sera were used to help determine the 4 c-ELISA positive-negative threshold levels and as the control reagents to determine the appropriate dilutions of the 4 c-ELISA antigens and their corresponding indicator antibodies. The third group of sera d originated from several horses, each of which was experimentally exposed to one of the 4 etiologic agents. Sera were collected from each animal, both preexposure and at intervals for at least 2 mo postexposure. These serially collected samples were used to evaluate the abilities of the cELISAs and the CF tests to detect antibodies in situations where seroconversion might be expected. These sera were considered to be gold standard positive sera.
cELISA procedure. Each of the 4 cELISA antigens was dispersed separately in 50 mM sodium bicarbonate buffer, pH 9.6, at a dilution previously optimized by titration against the homologous weak-positive control serum diluted to its CF endpoint. This approach helped ensure an adequate, but not an excessive, quantity of antigen for use in detecting competing serum antibody levels relative to a standardized indicator antibody challenge. This approach also helped ensure that CF and cELISA results would tend to be concor-dant and that a reference serum constant would be used to standardize antigen activity from lot to lot. Diluted antigens (75 l/well) were used to coat separate immunoassay plate wells e,f for 16 hr at 4 C. Plates were then frozen at Ϫ70 C until needed. For use, plates were thawed and washed twice in a high-salt (0.5 M NaCl) diluent (HSD) consisting of PBS to which was added an additional 21 g of sodium chloride and 4 ml of Tween 20 detergent g per liter of PBS. For piroplasmosis and dourine cELISAs, undiluted equine sera (50 l/well) were incubated in duplicate, adjacent wells of washed plates for 30 min at 37 C. For the glanders cELISA, sera were similarly incubated after first diluting and adsorbing them for 10 min at 37 C with a 4-fold volume of commercially available inactivated Pseudomonas aeruginosa cells. h Without washing the cELISA plates, each cELISA indicator antibody was diluted in HSD and added (50 l/ well) to the appropriate serum-containing wells for 30 min at 37 C. After this serum and indicator antibody coincubation, plates were washed as described above. Biotinylated anti-mouse IgG 1 (50 l/well) was then added to piroplasmosis and glanders tests wells and biotinylated anti-bovine IgG g (50 l/well) was added to dourine test wells for 30 min at 37 C. After this incubation, plates were washed as before and avidin-alkaline phosphatase conjugate 1 (50 l/well) was added to all wells for 15 min at room temperature. After 3 final washes, Bluephos substrate j (50 l/well) was added for 15 min, after which well optical densities (ODs) were measured k at 590 nanometers (OD 590 ).
The mean OD 590 of the duplicate wells exposed to each test serum was compared with the mean OD 590 of duplicate wells exposed to known seronegative equine serum. This comparison was expressed as a percentage OD 590 inhibition of test serum wells relative to the control serum wells: %OD 590 inhibition ϭ (1 Ϫ [OD 590 test serum Ϭ OD 590 control serum]) ϫ 100.
Alternative serologic tests. All sera tested by cELISA were also tested by piroplasmosis, dourine, and glanders CF procedures according to OIE and US Department of Agriculture protocols. The following established methods were used as additional tests on sera yielding discrepant cELISA and CF results: IFAT was used for B. equi and B. caballi serodiagnosis, immunoblotting (IB) was used for dourine serodiagnosis, and indirect ELISA (IELISA) was employed for glanders serologic testing. 6, 7, 9, 12, 17 
Results
Positive control sera. Each of the 8 positive control sera produced a substantial OD 590 reduction relative to the negative control serum ( Table 1) . Substantial OD 590 reductions were still evident after these sera were diluted in normal horse serum to their CF endpoints (Table 1). When these control sera were thus diluted, the cELISA positive-negative threshold %OD 590 inhibitions were estimated to be approximately 39%, 78%, 75%, and 74% for the dourine, B. equi, B. caballi, and glanders cELISA procedures, respectively (mean of CF endpoint serum dilution %OD 590 reductions for each pair of positive control sera). None of the positive control sera produced %OD 590 inhibitions in excess of 10% in any of the 3 nonhomologous cELISA procedures.
Negative serum bank. Each of the 4 cELISA procedures was evaluated for specificity (rate of false positives) with the 1,000 United States-origin equine sera presumed to be gold standard seronegative for piroplasmosis, dourine, and glanders. With this population of sera and the positive-negative thresholds described above, specificities of 98.9%, 99.2%, 99.5%, and 98.9% were determined for the dourine , B. equi, B . caballi, and glanders cELISAs, respectively. Test results on these sera were also used to calculate a normal population mean %OD 590 inhibition plus 3 standard deviations of that mean for each cELISA ( Table 2) . 16 These upper limits, which would theoretically encompass 99.9% of a normally distributed population, were 36% (6% ϩ [3 ϫ 10%]), 50% (8% ϩ [3 ϫ 14%]), 49% (7% ϩ [3 ϫ 14%]), and 45% (6% ϩ [3 ϫ 13%]) for the dourine, glanders, B. equi, and B. caballi procedures, respectively ( Table 2) . 16 Experimental exposure sera. With the OD 590 inhibition cutoffs that enabled 99.9% test specificity with the population of 1,000 normal horse sera, concor-dances and kappa values between the CF and the c-ELISA procedures were 76% and 0.55, 89% and 0.78, 70% and 0.44, and 97% and 0.95 for the B. equi, B. caballi, glanders, and dourine serodiagnostic procedures, respectively, when applied to the 4 groups of sera derived from experimentally exposed horses. 16 For each of the 4 groups of experimental exposure sera, half or more of the samples yielding discrepant negative CF-positive cELISA results were also classified as positive by the alternative serologic tests used (B. equi and B. caballi, IFAT; dourine, IB; glanders, IEL-ISA).
Discussion
This report describes a coordinated, procedurally similar cELISA approach to the serodiagnosis of equine piroplasmosis, dourine, and glanders. A battery of 4 CF procedures has been used for this purpose for many years. The data presented here indicate that the 4-way cELISA approach is highly specific and reasonably concordant with the equivalent 4-way CF test system.
With CF-positive serum control reagents diluted in normal serum to their CF endpoints, the threshold positive-negative %OD 590 reductions were empirically estimated at 39%, 78%, 75%, and 74% for the dourine, B. equi, B. caballi, and glanders cELISA procedures, respectively. With the exception of the dourine c-ELISA, there was a wide margin between these empirical thresholds and the statistical threshold generated by calculating the negative serum population mean %OD 590 inhibition plus 3 standard deviations of the mean (36%, 50%, 49%, 45%, respectively). Although the cELISA values of a negative serum population may not be, in fact, ideally normally distributed, the data do support the conclusion that the empirical cELISA thresholds selected will not frequently yield false-positive results when testing sera from unex- Table 3 . Comparison of CF and cELISA results with sera sequentially obtained from 4 horses for 60 days after experimental exposure to B. equi.
* Thirteen of 16 sera were positive by IFAT. All 4 horses were CF negative but still cELISA positive by 60 days postexposure. Each horse initially seroconverted to B. equi on the same day or earlier by cELISA than it seroconverted by CF. CF and cELISA concordance and kappa value ϭ 76% and 0.55. Table 5 . Comparison of CF and cELISA results with sera sequentially obtained from 6 horses for up to 90 days after experimental exposure to T. equiperdum.
* Two of 2 sera were negative by immunoblot, negative by CF. One serum sample was early postexposure (6 days), and 1 serum sample was 90 days postexposure.
† Two of 2 sera were positive by immunoblot, anticomplementary (AC) by CF. CF and cELISA concordance and kappa value ϭ 97% and 0.95. Table 6 . Comparison of CF and cELISA results with sera sequentially obtained 13 horses for up to 90 days after experimental exposure to B. mallei.
* Four of 5 sera were negative by IELISA.
† Nine of 11 sera were positive by IELISA. All of these sera were collected 42 days or longer postexposure.
‡ Four of 8 sera were positive by IELISA; these were CF suspect (S) sera.
§ Six of 6 sera were negative by IELISA; these were CF suspect (S) sera. CF and cELISA concordance and kappa value ϭ 70% and 0.44. * Four of 6 sera were positive by IFAT. All 4 horses were both CF and cELISA seropositive at 60 days postexposure. These 6 sera were collected 7-14 days postexposure when 2 of the 4 horses had seroconverted by cELISA but not by CF. CF and cELISA concordance and kappa value ϭ 89% and 0.78. posed normal horses. As demonstrated, the cELISA methods correlated as well as or better than the CF procedures with the alternative IFAT, IB, and IELISA methods used to examine sera yielding discrepant CF-cELISA results. The effectiveness of CF procedures in correctly identifying seropositive samples is known to be immunoglobulin class and subclass dependent for several diseases, including equine piroplasmosis. 5, 11, 12, 15, 17 Good evidence exists that, over time, equine CF responses to B. equi and B. caballi infections wane more rapidly than do IFAT or cELISA responses. 5, 11, 12, 15, 17 Patterns of CF response have also been investigated after experimental infections of horses with T. equiperdum and B. mallei. 1, 6, 7, 13 Although similar patterns of cELISA response have not been as extensively investigated for the latter 2 agents, the CF responses to them have also been shown to often wane or fluctuate erratically within a relatively short period after infection. Theoretically, cELISA procedures might be expected to be less immunoglobulin class and subclass dependent than CF procedures, and the c-ELISA procedures for dourine and glanders serodiagnosis would be expected to be superior to CF methods in detecting long-standing infections with those diseases as well. 5, 8, 11 Comparison of established procedures with new procedures can be made by traditional specificity cal-culations with the accepted and established procedures as gold standards. We chose not to do that with these CF and cELISA comparisons because of the many deficiencies of the piroplasmosis, dourine, and glanders CF procedures as noted above. Although the paired CF and cELISA test results on serum samples from experimentally exposed animals were substantially concordant, the supplemental IFAT, IB, and IELISA results on samples yielding discrepant CF-cELISA results agreed more often with cELISA than CF (Tables  3-6 ). This finding does not prove, but does suggest, that the cELISA procedures may actually be closer to gold standards as serodiagnotic tests than the CF tests, which are currently regarded as such for trade and regulatory testing purposes.
Each of the cELISA procedures described in this study can be performed in less time than the corresponding CF procedure. The cELISA procedures are reproducible, results are objectively measured and calculated, and the method is amenable to automation. Sera can be tested undiluted or with only minimal dilution, thus reducing opportunities for dilutional error, saving time, and possibly enhancing test sensitivities. All 4 cELISA tests utilize similar protocols, a single wash solution, conjugate, and indicator antibody diluent solutions, the same substrate, and the same method of data reduction. The cELISA system described in this work may be a superior replacement for the CF system currently used for the serodiagnosis of equine prioplasmosis, dourine, and glanders.
